Article
Impact of 13-valent pneumococal conjugate polysaccharide vaccination in exacerbations rate of COPD patients with moderate to severe obstruction.
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Aug 2017
Figueira-Gonçalves J M, Bethencourt-Martín N, Pérez-Méndez L I, Díaz-Pérez D, Guzmán-Sáenz C, Viña-Manrique P, Pedrero-García A J
Abstract excerpt
OBJECTIVE: One of the major microorganisms described as the cause of exacerbations of chronic obstructive pulmonary disease (COPD) is Streptococcus pneumoniae. The aim of this study is to evaluate the impact of 13-valent pneumococcal conjugate polysaccharide vaccine (PCV13) on COPD patients with regard to the development of exacerbations and the possible differential effect according to the patient's phenotype....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.